Pillstats
Rx only · Cream · Vaginal

Estradiol

Brands: Estrace · Estradiol

11 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US19 NDCs
11 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)4083
US makers12 labelers
Packages19
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 7 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$2.22$4.44$6.66$8.87Nov 2025Apr 2026Jul 2026
$1.437
Latest avg · Jul 22, 2026
-81%
Since Nov 19, 2025
11
Active US suppliers
50%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

57K113K170K226K2025 Q12025 Q22025 Q32025 Q42026 Q1
197K
Rx · 2026 Q1
8.3M
Units dispensed
+33%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it11 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
A-S Medication Solutionsunknown5SUPPLYING
Bryant Ranch Prepackrepackager4SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown1SUPPLYING
Mylan Pharmaceuticals Inc.unknown1SUPPLYING
Allergan, Inc.unknown1SUPPLYING
Encube Ethicals, Inc.unknown1SUPPLYING
Padagis Israel Pharmaceuticals Ltdunknown1SUPPLYING
NuCare Pharmaceuticals, Inc.unknown1SUPPLYING
Prasco Laboratoriesunknown1SUPPLYING
Redpharm Drugunknown1SUPPLYING
AvKAREunknown1SUPPLYING
Alvogen Inc.unknown1EXITED 2027

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.